… Introduction: Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in …
be paid to specific subgroups of patients who are at a greater risk of developing pneumonia. …

Rationale: Infants and young children might be particularly likely to experience the potential
clinical side effects of inhaled corticosteroids (ICSs) on body mass index (BMI), adiposity …

… an increased risk of progressive lung function impairments and fixed airflow obstruction,
there is ongoing debate on whether inhaled corticosteroids (ICS) modify these long-term risks. …

… In this narrative review, we will focus on the scientific evidence supporting treatment with
inhaled corticosteroids (ICS) in COPD, including treatment with combinations of long acting β-…

… patients had used inhaled corticosteroids in the previous year, … each additional canister of
inhaled corticosteroids used in the … after discontinuation of inhaled corticosteroids was higher …

… been used to develop new corticosteroids with greater topical … potency of the inhaled
corticosteroids is in the following rank … for any of the inhaled corticosteroids when administered in …

… We purposely chose infants with risk factors to develop asthma. … have major and/or minor
risk factors to develop asthma (8) do … the development of irreversible changes in the airways. …

… the risk-benefit ratio of inhaled corticosteroid treatment for … , and safety of inhaled corticosteroid
treatment in patients with COPD … risk of inhaled corticosteroid use for the development of …

… the development of epithelial tumor development [Citation7,Citation9]. The molecular mechanisms
underlying the development … a reduced risk of lung cancer development needs further …

… All levels of persistent asthma require daily anti-inflammatory treatment, and the safest,
most effective treatment for patients who have persistent asthma is inhaled corticosteroids (ICSs). …